Bill H.976: Expanding Vitiligo Treatment Access for All
UMass Medical School | Vitiligo Clinic & Research Center
by
9M ago
..read more
Visit website
Update About Villaris Therapeutics
UMass Medical School | Vitiligo Clinic & Research Center
by
1y ago
I’ve received many requests for updates about Villaris Therapeutics, the first company that I founded three and a half years ago to develop a new treatment for vitiligo. I am excited to share that an agreement was announced today whereby Villaris Therapeutics will be acquired by Incyte ..read more
Visit website
Opzelura, the first FDA-approved drug to treat vitiligo!
UMass Medical School | Vitiligo Clinic & Research Center
by
1y ago
Opzelura was already approved last September, 2021, for a disease called atopic dermatitis, or eczema, so you may have already seen it in the pharmacy. But most couldn’t get it covered by insurance for vitiligo because it wasn’t approved for it, and so NOW IT IS ..read more
Visit website
Vitiligo Research Participation Survey
UMass Medical School | Vitiligo Clinic & Research Center
by
2y ago
This study requires a large number of volunteers, so we are reaching out to gather information on the feasibility of recruiting participants. This will only work if we can get many volunteers to participate and stay in the study for the full period ..read more
Visit website
Vitiligo Repigmentation Study Opportunity
UMass Medical School | Vitiligo Clinic & Research Center
by
2y ago
RSVP study is specifically for those who have treatment-resistant vitiligo that is STABLE, or not changing for at least 1 year. The process being tested is to transplant pigment cells from one part of the body without vitiligo to another part that is affected by vitiligo ..read more
Visit website
IN HIS WORDS - Sudhit Rao
UMass Medical School | Vitiligo Clinic & Research Center
by
2y ago
Recently, I had the opportunity to visit the University of Massachusetts Medical School (UMMS), Vitiligo Clinic and Research Center in Worcester, MA. The visit gave me the privilege to interview Dr. John E. Harris, about his research, tour his lab, and even learn from his team of researchers. The session was not only educational but also an eye opener.   I wanted to share what I learnt with others who follow his research ..read more
Visit website
Phase 3 vitiligo clinical trial results to test topical ruxolitinib as a new treatment
UMass Medical School | Vitiligo Clinic & Research Center
by
3y ago
..read more
Visit website
Maybe it’s NOT vitiligo!
UMass Medical School | Vitiligo Clinic & Research Center
by
3y ago
Vitiligo is an autoimmune disease of the skin that causes white spots. It’s pretty distinctive and is frequently diagnosed by a dermatologist simply by looking at it, often with the aid of a special light called a Wood’s lamp. But I’ve seen patients in my Vitiligo Clinic, some who’ve traveled a very long distance (even other countries), who didn’t actually have vitiligo ..read more
Visit website
IN HER WORDS – Jillian Richmond
UMass Medical School | Vitiligo Clinic & Research Center
by
3y ago
in a series of blog posts I’m calling IN HER WORDS, and today will focus on Dr. Jillian Richmond. Dr. Richmond was a postdoctoral fellow in my lab who discovered that resident memory T cells are responsible for relapse of vitiligo after stopping treatments, and that we could target IL-15 to get rid of them and treat vitiligo. She now is an Assistant Professor in our department, and she’s studying other immune-mediated skin diseases like morphea and lupus. She has her own blog that you can read . In addition to her research program, she has a family, loves to teach students, and is an advocate ..read more
Visit website
What is Villaris Therapeutics and how will it help my vitiligo?
UMass Medical School | Vitiligo Clinic & Research Center
by
3y ago
I recently had the opportunity to start a new company entirely focused on developing a new treatment for vitiligo. We named the company Villaris Therapeutics, and the name was the concept of the board members, not me. I say that because it incorporates my last name, Harris, and I want it to be clear that it wasn’t my idea, although I am honored by it. Truth is, the long list of names I came up with for the company were either already taken, or weren’t that good, to be honest. So here we are, Villaris Therapeutics, which stands for . Now that’s out of the way, I’ll tell you a little more about ..read more
Visit website

Follow UMass Medical School | Vitiligo Clinic & Research Center on FeedSpot

Continue with Google
Continue with Apple
OR